Biology of transforming growth factor beta in hepatocarcinogenesis

Citation
W. Rossmanith et R. Schulte-hermann, Biology of transforming growth factor beta in hepatocarcinogenesis, MICROSC RES, 52(4), 2001, pp. 430-436
Citations number
83
Categorie Soggetti
Multidisciplinary
Journal title
MICROSCOPY RESEARCH AND TECHNIQUE
ISSN journal
1059910X → ACNP
Volume
52
Issue
4
Year of publication
2001
Pages
430 - 436
Database
ISI
SICI code
1059-910X(20010215)52:4<430:BOTGFB>2.0.ZU;2-Z
Abstract
TGF-beta is an important factor in the regulation of liver growth. It is an inhibitor of hepatocyte DNA synthesis and may induce active cell death, e. g., to remove excessive tissue mass. Studies using transgenic mice suggest that expression in the resting liver has to be well balanced; either under- or overexpression appear to cause an increased turnover of hepatocytes and to predispose to hepatocarcinogenesis. TGF-beta overexpression is frequent ly observed in human hepatocellular carcinomas, probably as a late event in tumor development. In men and mice, TGF-beta overexpression appears to be associated with loss of TGF-beta responsiveness often by disruption of TGF- beta signaling. However, mechanisms as mutations in TGF-beta receptor II or Smad2 and 4 genes, frequently observed in other human cancers, have only r arely been observed in hepatocellular carcinomas. Further studies may clari fy the mechanisms by which hepatocellular tumors escape TGF-beta growth con trol, as well as analyze possible roles of TGF-beta overexpression in immun osuppression and angiogenesis. Microsc. Res. Tech. 52:430-436, 2001. (C) 20 01 Wiley-Liss, Inc.